advertisement
Lee D 29
Showing records 1 to 25 | Display all abstracts from Lee D104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Wong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Wong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Snider MJE
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Xu H
Ophthalmology. Glaucoma 2022; 5: 658-662
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Lee D
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Lee D
Ophthalmology. Glaucoma 2022; 5: 658-662
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Huang D
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Shiuey EJ; Razeghinejad R
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Wong JC
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Cho J
Ophthalmology. Glaucoma 2022; 5: 658-662
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Chiang B
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Wong JC
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Shukla AG; Shukla AG
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Voss J
Ophthalmology. Glaucoma 2022; 5: 658-662
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Gupta S
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Patel LG
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Khalifa Y
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Ammar M
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
McDaniel L
Ophthalmology. Glaucoma 2022; 5: 658-662
103956 Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals
Maa AY
Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 2022; 28: 1134-1142
104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
An JA
Ophthalmology. Glaucoma 2022; 5: 658-662
